Biogen Idec Selects Evotec OAI as a Service Provider for Process Research & Development.

(From Hugin)

Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------

Hamburg, Germany | Oxford, UK - Evotec OAI AG (Frankfurt Stock Exchange: EVT, TecDAX 30), a leading partner for integrated, high-value-added drug discovery and development solutions, today announced that Biogen Idec (Nasdaq: BIIB) has selected Evotec OAI as one of its service providers for chemical process research and development and cGMP manufacturing. The companies have expanded their relationship under a master services …